AU588299B2
(en)
*
|
1985-04-08 |
1989-09-14 |
Rafa Laboratories Ltd. |
Artificial microcompartmentalization
|
US5409704A
(en)
*
|
1985-06-26 |
1995-04-25 |
The Liposome Company, Inc. |
Liposomes comprising aminoglycoside phosphates and methods of production and use
|
WO1987000043A1
(en)
*
|
1985-07-05 |
1987-01-15 |
The Liposome Company, Inc. |
Multilamellar liposomes having improved trapping efficiencies
|
FR2628317B1
(fr)
*
|
1988-03-09 |
1991-11-08 |
Lvmh Rech |
Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de scutellaria, ou au moins un flavonoide tel que baicaleine ou baicaline et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite anti-allergique, anti-inflammatoire ou anti-vieillissement, l'incorporant
|
MX9203504A
(es)
*
|
1988-04-20 |
1992-07-01 |
Liposome Co Inc |
Complejo agente: lipido activo de alta proporcion.
|
DE68916956T2
(de)
*
|
1988-05-20 |
1994-11-24 |
Liposome Co Inc |
Aktives mittel: lipid-komplex mit hohem verhältnis.
|
IL90561A
(en)
*
|
1988-06-08 |
1993-08-18 |
Fountain Pharm Inc |
Method for making solvent dilution microcarriers
|
US5269979A
(en)
*
|
1988-06-08 |
1993-12-14 |
Fountain Pharmaceuticals, Inc. |
Method for making solvent dilution microcarriers
|
US4952405A
(en)
*
|
1988-10-20 |
1990-08-28 |
Liposome Technology, Inc. |
Method of treating M. avium infection
|
WO1990004412A1
(en)
*
|
1988-10-27 |
1990-05-03 |
Regents Of The University Of Minnesota |
Liposome immunoadjuvants containing il-2
|
DE69032161T2
(de)
*
|
1989-05-25 |
1998-11-19 |
Technology Unlimited Inc |
Abstossmittel für insekten
|
ZA911974B
(en)
*
|
1990-03-21 |
1994-08-22 |
Res Dev Foundation |
Heterovesicular liposomes
|
US5264220A
(en)
*
|
1991-11-12 |
1993-11-23 |
Long David M Jr |
Method of extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents
|
EP0624095B2
(en)
*
|
1991-12-31 |
2005-07-20 |
Zymogenetics, Inc. |
Methods and compositions for reducing blood loss
|
EP0585514B1
(en)
*
|
1992-01-09 |
1998-10-07 |
LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d., Ljubljana |
Animal feed and an additive thereto or to drinking water containing an antibiotic mixture of gentamicin with lincomycin or clindamycin
|
US5674855A
(en)
*
|
1992-08-12 |
1997-10-07 |
The Rogosin Institute |
Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
|
US5344822A
(en)
*
|
1992-08-12 |
1994-09-06 |
The Rogosin Institute |
Methods useful in endotoxin prophylaxis and therapy
|
US5958449A
(en)
|
1992-12-02 |
1999-09-28 |
Nexstar Pharmaceuticals, Inc. |
Antibiotic formulation and use for bacterial infections
|
WO1994012155A1
(en)
*
|
1992-12-02 |
1994-06-09 |
Vestar, Inc. |
Antibiotic formulation and process
|
US5759571A
(en)
*
|
1993-05-11 |
1998-06-02 |
Nexstar Pharmaceuticals, Inc. |
Antibiotic formulation and use for drug resistant infections
|
US5478819A
(en)
*
|
1993-06-23 |
1995-12-26 |
Simo Tarpila |
Phospholipid composition and use thereof
|
WO1995008344A1
(en)
*
|
1993-09-22 |
1995-03-30 |
Xoma Corporation |
Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein product and antibiotic
|
EP0664117A1
(de)
*
|
1994-01-25 |
1995-07-26 |
F. Hoffmann-La Roche Ag |
Liposomenlösungen
|
US20020028215A1
(en)
|
1999-08-09 |
2002-03-07 |
Jagath L. Kadurugamuwa |
Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
|
US6096336A
(en)
*
|
1996-01-30 |
2000-08-01 |
The Stehlin Foundation For Cancer Research |
Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
|
US5874105A
(en)
*
|
1996-01-31 |
1999-02-23 |
Collaborative Laboratories, Inc. |
Lipid vesicles formed with alkylammonium fatty acid salts
|
US6071535A
(en)
*
|
1996-01-31 |
2000-06-06 |
Collaborative Laboratories, Inc. |
Lipid vesicles formed with alkylammonium fatty acid salts
|
US6183774B1
(en)
|
1996-01-31 |
2001-02-06 |
Collaborative Laboratories, Inc. |
Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts
|
DE69736428T2
(de)
|
1996-05-08 |
2007-08-30 |
Biogen Idec Ma Inc., Cambridge |
RET-LIGAND 3 (RetL3), UM NEURALES UND RENALES WACHSTUM ZU STIMULIEREN
|
AU4151697A
(en)
*
|
1996-08-14 |
1998-03-06 |
Vanderbilt University |
Compositions of antichlamydial agents for the diagnosis and management of infection caused by (chlamydia)
|
US5935572A
(en)
*
|
1997-01-10 |
1999-08-10 |
Collaborative Laboratories, Inc. |
Composition containing protease separate from glycosidase for removing nits in treating lice infestation
|
US6613352B2
(en)
|
1999-04-13 |
2003-09-02 |
Universite De Montreal |
Low-rigidity liposomal formulation
|
US6352996B1
(en)
|
1999-08-03 |
2002-03-05 |
The Stehlin Foundation For Cancer Research |
Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
|
AU2002334761A1
(en)
*
|
2001-10-01 |
2003-04-14 |
The Board Of Trustees Of The University Of Illinois |
Methods of treating drug-resistant bacterial infections
|
US20080075762A1
(en)
*
|
2001-10-03 |
2008-03-27 |
Paul Tardi |
Compositions for delivery of drug combinations
|
US7850990B2
(en)
|
2001-10-03 |
2010-12-14 |
Celator Pharmaceuticals, Inc. |
Compositions for delivery of drug combinations
|
CA2383259A1
(en)
|
2002-04-23 |
2003-10-23 |
Celator Technologies Inc. |
Synergistic compositions
|
US20030228402A1
(en)
*
|
2002-02-19 |
2003-12-11 |
Franklin Lanny U. |
Compositions and methods for preservation of food
|
WO2003075890A1
(en)
*
|
2002-03-05 |
2003-09-18 |
Transave, Inc. |
Methods for entrapment of bioactive agent in a liposome or lipid complex
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
US7879351B2
(en)
*
|
2002-10-29 |
2011-02-01 |
Transave, Inc. |
High delivery rates for lipid based drug formulations, and methods of treatment thereof
|
ES2831305T3
(es)
*
|
2002-10-29 |
2021-06-08 |
Insmed Inc |
Liposomas que comprenden un aminoglucósido para el tratamiento de infecciones pulmonares
|
US6846966B2
(en)
*
|
2002-11-26 |
2005-01-25 |
Exxonmobil Chemical Patents Inc. |
Method and apparatus for treating oxygenate-containing feeds and their use in conversion of oxygenates to olefins
|
FR2852513A1
(fr)
*
|
2003-03-17 |
2004-09-24 |
Groupe Lepine |
Combinaison d'antibiotiques gentamicine/clindamycine et ses applications aux ciments orthopediques curatifs
|
RU2385323C2
(ru)
|
2003-04-02 |
2010-03-27 |
ДЗЕ ГАВЕРМЕНТ ОФ ДЗЕ ЮНАЙТЕД СТЕЙТС ОФ АМЕРИКА Эз репрезентед бай ДЗЕ СЕКРЕТЭРИ, ДЕПАРТМЕНТ ОФ ХЕЛТ ЭНД ХЬЮМЭН СЕРВИСИЗ |
Холестеринсодержащие соединения и их применение в качестве иммуногенов против borrelia burgdorferi
|
US20040204435A1
(en)
*
|
2003-04-09 |
2004-10-14 |
Joachim Liehr |
Alternating treatment with topoisomerase I and topoisomerase II inhibitors
|
US9845344B2
(en)
|
2004-03-30 |
2017-12-19 |
Hoba Therapeutics Aps |
Therapeutic use of a growth factor, NsG33
|
WO2006013462A2
(en)
*
|
2004-07-30 |
2006-02-09 |
Nsgene A/S |
Growth factors nsg28, nsg30, and nsg32
|
WO2006032136A1
(en)
*
|
2004-09-20 |
2006-03-30 |
British Columbia Cancer Agency Branch |
Free or liposomal gemcitabine alone or in combination with free or liposomal idarubicin
|
US20110020434A1
(en)
*
|
2005-09-02 |
2011-01-27 |
O'halloran Thomas V |
Nanoparticle arsenic-platinum compositions
|
DE102005063375A1
(de)
*
|
2005-09-15 |
2007-04-19 |
Schülke & Mayr GmbH |
Antimikrobielle Zubereitungen mit einem Gehalt an Octenidindihydrochlorid verkapselt in Liposomen
|
EP2218442A1
(en)
|
2005-11-09 |
2010-08-18 |
CombinatoRx, Inc. |
Methods, compositions, and kits for the treatment of ophthalmic disorders
|
EP3718532A1
(en)
|
2005-12-08 |
2020-10-07 |
Insmed Incorporated |
Lipid-based compositions of antiinfectives for treating pulmonary infections
|
US20100196455A1
(en)
*
|
2007-05-04 |
2010-08-05 |
Transave, Inc. |
Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
US8470762B2
(en)
*
|
2007-05-31 |
2013-06-25 |
Colgate-Palmolive Company |
Fabric softening compositions comprising polymeric materials
|
WO2009108407A1
(en)
*
|
2008-02-25 |
2009-09-03 |
The University Of North Carolina At Charlotte Office Of Technology Transfer |
Biodegradable therapeutic nanoparticles containing an antimicrobial agent
|
EP3246034A1
(en)
|
2008-03-06 |
2017-11-22 |
Anacor Pharmaceuticals, Inc. |
Boron-containing small molecules as anti-inflammatory agents
|
EP3485881B1
(en)
|
2009-07-10 |
2024-03-13 |
President and Fellows of Harvard College |
Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
|
AU2010330747B2
(en)
|
2009-12-18 |
2016-08-11 |
Achelios Therapeutics, Inc. |
Methods and compositions for treating and preventing trigeminal autonomic cephalgias, migraine, and vascular conditions
|
US8716478B2
(en)
|
2010-01-27 |
2014-05-06 |
Anacor Pharmaceuticals, Inc. |
Boron-containing small molecules
|
CN103339149B
(zh)
|
2010-06-14 |
2016-02-03 |
H.隆德贝克有限公司 |
SorLA和GDNF-家族配体受体之间的相互作用的调节
|
ES2606781T3
(es)
*
|
2010-07-23 |
2017-03-27 |
Acea Biotech, Inc. |
Macrólidos polienos antifúngicos y antiparasitarios
|
ES2584068T3
(es)
|
2010-10-01 |
2016-09-23 |
Nsgene A/S |
Uso de meteorina para el tratamiento de alodinia, hiperalgesia, dolor espontáneo y dolor fantasma
|
EP2852391B1
(en)
|
2012-05-21 |
2021-11-17 |
Insmed Incorporated |
Systems for treating pulmonary infections
|
RU2018135921A
(ru)
|
2012-11-29 |
2019-02-05 |
Инсмед Инкорпорейтед |
Стабилизированные составы ванкомицина
|
ES2755941T3
(es)
|
2014-05-15 |
2020-04-24 |
Insmed Inc |
Métodos para tratar infecciones pulmonares micobacterianas no tuberculosas
|
US10791740B2
(en)
*
|
2014-06-06 |
2020-10-06 |
The Curators Of The University Of Missouri |
Enhancement of antibiotic efficacy
|
EP3226972A4
(en)
|
2014-12-01 |
2018-08-08 |
Achelios Therapeutics, Inc. |
Methods and compositions for treating migraine and conditions associated with pain
|
JP6833811B2
(ja)
|
2015-08-03 |
2021-02-24 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
荷電イオンチャネル遮断薬及び使用方法
|
US11981703B2
(en)
|
2016-08-17 |
2024-05-14 |
Sirius Therapeutics, Inc. |
Polynucleotide constructs
|
US11597744B2
(en)
|
2017-06-30 |
2023-03-07 |
Sirius Therapeutics, Inc. |
Chiral phosphoramidite auxiliaries and methods of their use
|
WO2019191627A1
(en)
|
2018-03-30 |
2019-10-03 |
Insmed Incorporated |
Methods for continuous manufacture of liposomal drug products
|
WO2020185881A1
(en)
|
2019-03-11 |
2020-09-17 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
CA3129089A1
(en)
|
2019-03-11 |
2020-09-17 |
Bridget Mccarthy Cole |
Ester substituted ion channel blockers and methods for use
|
US11377422B2
(en)
|
2019-03-11 |
2022-07-05 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
US10780083B1
(en)
|
2019-03-11 |
2020-09-22 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
US10828287B2
(en)
|
2019-03-11 |
2020-11-10 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
EP4054586A4
(en)
|
2019-11-06 |
2023-11-22 |
Nocion Therapeutics, Inc. |
CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE
|
JP2023500891A
(ja)
|
2019-11-06 |
2023-01-11 |
ノシオン セラピューティクス,インコーポレイテッド |
荷電したイオンチャンネル遮断薬および使用方法
|
WO2021183639A1
(en)
|
2020-03-11 |
2021-09-16 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
WO2022233989A1
(en)
|
2021-05-06 |
2022-11-10 |
Hoba Therapeutics Aps |
Prevention and treatment of chemotherapy-induced neuropathic pain
|
CA3239550A1
(en)
|
2021-12-10 |
2023-06-15 |
Kenneth Petersen |
Treatment of nociceptive pain
|